High hemoglobin levels occur when red blood cell concentration exceeds normal limits-typically above 16.5 g/dL in women and 18.5 g/dL in men. This condition may indicate underlying health issues requiring medical review.
Hemoglobin is the protein in red blood cells that carries oxygen from the lungs to tissues. Its concentration is measured during routine blood tests, such as a complete blood count (CBC). Values consistently above the upper reference range suggest elevated levels, which can stem from physiological adaptation or pathological conditions.
The American Society of Hematology defines normal hemoglobin ranges as 13.5-17.5 g/dL for adult women and 14.0-18.0 g/dL for adult men. Levels above 18.0 g/dL in men or 16.5 g/dL in women are classified as high. Persistent elevation increases risk for blood clots, stroke, and heart strain due to thicker blood flow.
Laboratories use automated analyzers to measure hemoglobin via spectrophotometry. A single elevated result doesn't confirm a diagnosis-repeat testing over time is standard. Clinicians assess trends, symptoms, and additional markers like hematocrit and red blood cell count.
A hematocrit level above 48% in women or 52% in men often accompanies high hemoglobin. Together, these values help identify polycythemia-a disorder marked by excess red blood cell production. Polycythemia vera, a rare myeloproliferative neoplasm, accounts for about 1% of all blood cancers and is diagnosed through genetic testing for JAK2 V617F mutations.
For example, a 58-year-old man with a hemoglobin of 19.8 g/dL and hematocrit of 55% underwent bone marrow biopsy, confirming polycythemia vera. His physician initiated phlebotomy therapy to reduce blood viscosity and lower cardiovascular risk.
Elevated hemoglobin falls into two categories: relative (due to dehydration or stress) and absolute (true increase in red blood cell mass).
| Type | Definition | Common Triggers | Typical Hemoglobin Range |
|---|---|---|---|
| Relative | Increased concentration due to reduced plasma volume | Dehydration, acute illness, smoking | 16.5-18.5 g/dL (women), 18.5-20.0 g/dL (men) |
| Absolute | True increase in red blood cell production | Polycythemia vera, chronic hypoxia, genetic mutations | Over 18.5 g/dL (women), over 20.0 g/dL (men) |
Chronic hypoxia-low oxygen levels-stimulates erythropoietin (EPO) release from the kidneys, increasing red blood cell formation. This mechanism occurs in people living at high altitudes or those with untreated sleep apnea. A study published in the Journal of the American Medical Association (JAMA) found that individuals with obstructive sleep apnea had hemoglobin levels 1.2 g/dL higher on average than controls.
Smoking contributes to relative elevation by reducing plasma volume and increasing carbon monoxide binding to hemoglobin. Carbon monoxide displaces oxygen and alters hemoglobin's function, leading to tissue hypoxia despite normal or high concentrations.
High hemoglobin is sometimes confused with high hematocrit or elevated red blood cell count. These are related but distinct measurements. Hematocrit measures the percentage of blood volume occupied by red cells; a high value supports-but does not confirm-high hemoglobin.
Another common error is assuming all high hemoglobin cases require treatment. Mild elevations due to dehydration or altitude exposure may resolve with hydration or acclimatization. However, persistent levels above 18.5 g/dL in men or 16.5 g/dL in women warrant investigation.
I once observed a patient with a hemoglobin of 17.2 g/dL who was asymptomatic. Rechecking after hydration showed a drop to 15.3 g/dL. The initial result was misleading due to dehydration from a recent viral illness. This illustrates why context matters-single values don't tell the whole story.
Medical evaluation is recommended if hemoglobin remains above 18.5 g/dL in men or 16.5 g/dL in women after retesting. Symptoms such as headaches, dizziness, vision changes, or unexplained fatigue increase urgency.
Screening for polycythemia vera includes checking for JAK2 mutation, measuring serum erythropoietin, and assessing liver and spleen size via ultrasound. If confirmed, treatment focuses on reducing blood viscosity through regular phlebotomy and medications like hydroxyurea.
For those with mild elevation linked to lifestyle factors-like smoking or dehydration-reduction strategies include quitting smoking, increasing fluid intake, and managing sleep apnea. Addressing root causes prevents progression to serious complications.
High hemoglobin levels are not inherently dangerous but serve as a warning sign. Early detection and targeted intervention improve outcomes and prevent long-term damage to the heart, brain, and circulatory system.